CRH Stock Analysis: CRH | NYSE
Building Materials | NYSE, USA | Market Cap: 52.691m USD | 12M Return: -27.4% | IE0001827041 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 454M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CRH plc is a Dublin-based building materials company founded in 1936, operating across Ireland, the United States, the United Kingdom, and the broader European market. The business is organized into three segments-Americas Materials Solutions, Americas Building Solutions, and International Solutions-covering a vertically integrated range of products and services from raw materials to finished building components.
The company supplies aggregates, cementitious materials, ready-mixed concrete, asphalt, and precast/prestressed concrete products such as vaults, pipes, and manholes. It also manufactures hardscape and related building products and delivers infrastructure solutions for water, energy, transportation, and telecommunications projects, serving both public infrastructure and private construction end markets.
As a major player in the construction materials sector, CRH benefits from exposure to long-cycle demand drivers such as infrastructure investment, residential construction, and utility network expansion. Aggregates and cement tend to be heavy, low value-to-weight commodities, meaning the industrys economics are heavily shaped by proximity of reserves to end markets and logistical efficiency-factors that have driven the sectors wave of consolidation in recent decades.
- US infrastructure spending boosts aggregates and cement demand
- Housing slowdown pressures Americas Building Solutions volumes
- Energy and input costs squeeze cement margins
| Net Income: 3.84b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.67 > 1.0 |
| NWC/Revenue: 14.95% < 20% (prev 17.79%; Δ -2.84% < -1%) |
| CFO/TA 0.09 > 3% & CFO 5.42b > Net Income 3.84b |
| Net Debt (18.7b) to EBITDA (8.25b): 2.26 < 3 |
| Current Ratio: 1.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (668.8m) vs 12m ago -1.31% < -2% |
| Gross Margin: 36.25% > 18% (prev 35.99%; Δ 0.26% > 0.5%) |
| Asset Turnover: 68.66% > 50% (prev 67.33%; Δ 1.33% > 0%) |
| Interest Coverage Ratio: 7.03 > 6 (EBIT TTM 5.99b / Interest Expense TTM 852.0m) |
| A: 0.10 (Total Current Assets 15.8b - Total Current Liabilities 9.98b) / Total Assets 58.6b |
| B: 0.44 (Retained Earnings 25.7b / Total Assets 58.6b) |
| C: 0.11 (EBIT TTM 5.99b / Avg Total Assets 56.3b) |
| D: 0.73 (Book Value of Equity 24.0b / Total Liabilities 33.0b) |
| Altman-Z'' = 3.56 = A |
| DSRI: 0.98 (Receivables 6.78b/6.49b, Revenue 38.6b/36.3b) |
| GMI: 0.99 (GM 35.99% / 36.25%) |
| AQI: 1.06 (AQ_t 0.28 / AQ_t-1 0.27) |
| SGI: 1.06 (Revenue 38.6b / 36.3b) |
| TATA: -0.03 (NI 3.84b - CFO 5.42b) / TA 58.6b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of October 17, 2026, the stock is trading at USD 83.63 with a total of 7,699,686 shares traded. Over the past week, the price has changed by +2.56%, over one month by -3.54%, over three months by -20.48% and over the past year by -27.44%.
Current recommended Stop Loss: 80.50 (which is 3.7% or 1.4 ATR below the current price).
CRH has received a consensus analysts rating of 4.70. Therefore, it is recommended to buy CRH.
- StrongBuy: 17
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 126.5 | 51.3% |
P/E Trailing = 14.1682
P/E Forward = 12.9702
P/S = 1.3639
P/B = 2.3592
P/EG = 1.5259
Revenue TTM = 38.6b USD
EBIT TTM = 5.99b USD
EBITDA TTM = 8.25b USD
Long Term Debt = 15.4b USD (from longTermDebt, last quarter)
Short Term Debt = 2.89b USD (from shortTermDebt, last quarter)
Debt = 21.7b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.89b
Net Debt = 18.7b USD (calculated: Debt 21.7b - CCE 3.02b)
Enterprise Value = 71.4b USD (52.7b + Debt 21.7b - CCE 3.02b)
Interest Coverage Ratio = 7.03 (Ebit TTM 5.99b / Interest Expense TTM 852.0m)
EV/FCF = 25.80x (Enterprise Value 71.4b / FCF TTM 2.77b)
FCF Yield = 3.88% (FCF TTM 2.77b / Enterprise Value 71.4b)
FCF Margin = 7.16% (FCF TTM 2.77b / Revenue TTM 38.6b)
Net Margin = 9.93% (Net Income TTM 3.84b / Revenue TTM 38.6b)
Gross Margin = 36.25% ((Revenue TTM 38.6b - Cost of Revenue TTM 24.6b) / Revenue TTM)
Gross Margin QoQ = 39.84% (prev 27.75%)
Tobins Q-Ratio = 1.22 (Enterprise Value 71.4b / Total Assets 58.6b)
Interest Expense / Debt = 3.93% (Interest Expense 852.0m / Debt 21.7b)
Taxrate = 24.93% (1.28b / 5.13b)
NOPAT = 4.49b (EBIT 5.99b * (1 - 24.93%))
Current Ratio = 1.58 (Total Current Assets 15.8b / Total Current Liabilities 9.98b)
Debt / Equity = 0.90 (Debt 21.7b / totalStockholderEquity, last quarter 24.0b)
Debt / EBITDA = 2.26 (Net Debt 18.7b / EBITDA 8.25b)
Debt / FCF = 6.75 (Net Debt 18.7b / FCF TTM 2.77b)
Total Stockholder Equity = 23.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.82% (Net Income 3.84b / Total Assets 58.6b)
RoE = 16.26% (Net Income TTM 3.84b / Total Stockholder Equity 23.6b)
RoCE = 15.34% (EBIT 5.99b / Capital Employed (Equity 23.6b + L.T.Debt 15.4b))
RoIC = 9.07% (NOPAT 4.49b / Invested Capital 49.5b)
WACC = 7.93% (E(52.7b)/V(74.4b) * Re(9.98%) + D(21.7b)/V(74.4b) * Rd(3.93%) * (1-Tc(0.25)))
Discount Rate = 9.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.05 | Cagr: -1.59%
[DCF] Terminal Value 77.97% ; FCFF base≈2.53b ; Y1≈2.91b ; Y5≈4.28b
[DCF] Fair Price = 68.65 (EV 64.3b - Net Debt 18.7b = Equity 45.7b / Shares 665.3m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 26.06 | EPS CAGR: 3.88% | SUE: 2.43 | # QB: 1
Revenue Correlation: 43.13 | Revenue CAGR: 3.36% | SUE: 0.37 | # QB: 0
EPS current Quarter (2026-09-30): EPS=2.10 | Chg30d=-5.72% | Revisions=-25% | Analysts=6
EPS current Year (2026-12-31): EPS=5.72 | Chg30d=-2.30% | Revisions=-44% | GrowthEPS=+1.8% | GrowthRev=+5.7%
EPS next Year (2027-12-31): EPS=6.39 | Chg30d=-2.03% | Revisions=-55% | GrowthEPS=+12.4% | GrowthRev=+5.3%
[Analyst] Revisions Ratio: -61% (up=2, down=13)